C9356 HCPCS Level II code: Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
C9356 is the HCPCS code for “Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
C9356Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
Short description: Tenoglide tendon prot, cm2
HCPCS · United States
Medicare details
The indicators CMS publishes with C9356 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Statute
- Type of service
- Other medical items or services
- BETOS category
- Medical/surgical supplies
- Coverage statute
- 621 MMA
- Added
- Jul 1, 2008
Where C9356 sits
- 1C codesOutpatient prospective payment system
- 2Active code C9356Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code C9356 mean?
C9356 is the HCPCS code for “Tendon, porous matrix of cross-linked collagen and glycosaminoglycan matrix (tenoglide tendon protector sheet), per square centimeter” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover C9356?
CMS lists C9356’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Statute”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside C9356
All C codesC9313Injection, pivekimab sunirine-pvzy, 0.01 mgC9349Puraply, and puraply antimicrobial, any type, per square centimeterC9352Microporous collagen implantable tube (neuragen nerve guide), per centimeter lengthC9353Microporous collagen implantable slit tube (neurawrap nerve protector), per centimeter lengthC9354Acellular pericardial tissue matrix of non-human origin (veritas), per square centimeterC9355Collagen nerve cuff (neuromatrix), per 0.5 centimeter lengthC9358Dermal substitute, native, non-denatured collagen, fetal bovine origin (surgimend collagen matrix), per 0.5 square centimetersC9359Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold putty, integra os osteoconductive scaffold putty), per 0.5 ccC9360Dermal substitute, native, non-denatured collagen, neonatal bovine origin (surgimend collagen matrix), per 0.5 square centimetersC9361Collagen matrix nerve wrap (neuromend collagen nerve wrap), per 0.5 centimeter lengthC9362Porous purified collagen matrix bone void filler (integra mozaik osteoconductive scaffold strip), per 0.5 ccC9363Skin substitute, integra meshed bilayer wound matrix, per square centimeter